Every lot independently tested — see its certificate of analysis before you buy.Batch-linked purity, price and stock — the exact vial on our shelf, never an aggregate.
Skin & tissue peptides

GHK-Cu

Copper tripeptide of research interest

Coming soon
GHK-Cu
Batch
GHK-26-001
Fig. 02, Vial

Specifications
Molecular formulaC14H22CuN6O4
Molecular weight401.93 g/mol
CAS number89030-95-5
SequenceGHK
SKUPTN-GHK-50MG
Vial size50 mg
Batch verification· GHK-26-001
Pending
Purity (HPLC)
1 Jun 2026
Received
Testing in progress

HPLC certificate of analysis pending — typically published within a month of batch receipt.

01

Research at a glance

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex, also called copper tripeptide-1) is a copper-binding tripeptide derived from a sequence that occurs naturally in human plasma, urine, and other body fluids. The literature characterises it as a copper-carrying biomimetic peptide studied chiefly in the context of skin delivery, cosmetic formulation, and antioxidant/anti-inflammatory mechanisms, with attention to its limited permeation through the stratum corneum. The evidence base is predominantly in vitro, formulation-based, and invertebrate/animal model work, with controlled human data remaining limited.

  • In a review of cosmetically active compounds, GHK-Cu has been characterised as a hydrophilic tripeptide with limited permeation through the lipophilic stratum corneum, and liposomal encapsulation has been discussed as an approach studied for improving its skin transport.[1]

    Review
    Emerging
  • In in vitro and in vivo LPS-induced inflammation models, a GHK-Cu-loaded hydroxyapatite microsphere gel filler was associated with reduced inflammatory factor and reactive oxygen species levels alongside increased superoxide dismutase, in a study focused on sustained peptide release.[2]

    In vitroAnimal
    Preliminary
  • In a formulation study, GHK-Cu has been studied as a cargo for anionic and cationic lecithin-based liposomes, with characterisation of encapsulation efficiency and in vitro tyrosinase and elastase inhibition assays.[3]

    In vitro
    Preliminary
  • In the model organism Caenorhabditis elegans, GHK-Cu administration was associated with extended lifespan and altered aging-related phenotypes, including enhanced oxidative and thermal stress resistance and changes in mitochondrial function linked to DAF-16/SKN-1 pathway activation.[4]

    Animal
    Preliminary

02

What the research does not show

The human evidence identified in this search is limited in scale; larger controlled trials establishing exposure and long-term safety in humans are not yet available.


03

Handling & storage

Storage reference

Lyophilized (sealed): store at −20 °C, protected from light.

Reconstituted: store at 2–8 °C; use within a few weeks.

Avoid repeated freeze–thaw cycles and prolonged light exposure.

Reconstitution reference — concentration calculator

Enter a volume of bacteriostatic water to see the resulting concentration of the reconstituted vial.

25mg / mL
In a 0.05 mL draw1.25 mg
In a 0.1 mL draw2.5 mg
In a 0.2 mL draw5 mg

A concentration reference for lab handling — not a dose or administration instruction.


04

References

References (8)
  1. 1.
    Ogórek K et al., Molecules (Basel, Switzerland) 2025
    Molecules (Basel, Switzerland), 2025· Review
  2. 2.
    Hu D et al., Colloids and surfaces. B, Biointerfaces 2025
    Colloids and surfaces. B, Biointerfaces, 2025· In vitro, Animal
  3. 3.
    Dymek M et al., Pharmaceutics 2023
    Pharmaceutics, 2023· In vitro
  4. 4.
    Wen H et al., Biogerontology 2026
    Biogerontology, 2026· Animal
  5. 5.
  6. 6.
    Zhang Q et al., Frontiers in molecular biosciences 2022
    Frontiers in molecular biosciences, 2022
  7. 7.
    Ha JW et al., Antioxidants (Basel, Switzerland) 2023
    Antioxidants (Basel, Switzerland), 2023
  1. 1.Pickart, GHK and copper-peptide research overview · BioMed Research International, 2015

Sources last reviewed 19 Jul 2026